Detalhe da pesquisa
1.
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.
Circulation
; 104(4): 406-11, 2001 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-11468201
2.
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation
; 102(10): 1093-100, 2000 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-10973836
3.
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
Circulation
; 102(10): 1101-6, 2000 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-10973837
4.
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
J Am Coll Cardiol
; 33(1): 88-96, 1999 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-9935014
5.
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.
J Am Coll Cardiol
; 37(2): 492-8, 2001 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11216968
6.
Neuroinflammation in the normal aging hippocampus.
Neuroscience
; 309: 84-99, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772789
7.
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Am J Cardiol
; 85(4): 427-34, 2000 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10728945
8.
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
Am J Cardiol
; 88(10): 1097-102, 2001 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11703951
9.
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Am J Cardiol
; 83(8): 1147-51, 1999 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10215274
10.
Nonimmunogenicity of eptifibatide, a cyclic heptapeptide inhibitor of platelet glycoprotein IIb-IIIa.
Clin Ther
; 21(1): 128-37, 1999 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-10090430
11.
Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina.
Clin Cardiol
; 19(11): 869-74, 1996 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8914780
12.
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation.
Neurogastroenterol Motil
; 22(1): 42-9, e7-8, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19691492
13.
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor.
Eur Heart J
; 16 Suppl L: 50-5, 1995 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8869019
14.
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Eur J Cancer Clin Oncol
; 22(3): 245-9, 1986 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-2940092
15.
A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer.
Gastroenterology
; 96(4): 967-71, 1989 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-2647578
16.
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.
JAMA
; 285(19): 2468-73, 2001 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-11368699
17.
Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention.
Am Heart J
; 140(6): 834-9, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11099985
18.
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
Circulation
; 95(4): 846-54, 1997 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-9054741
19.
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
Circulation
; 94(9): 2083-9, 1996 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8901655